A Telephone Cardiopulmonary Resuscitation (TCPR) program increased survival rates and favorable outcomes for patients who experienced an out-of-hospital cardiac arrest, according to a study…
A small, early study in the Journal of Clinical Investigation reports that 93% of patients with advanced leukemia were in remission after immunotherapy. Read…
On April 22, the U.S. the Food and Drug Administration (FDA) proposed a ban on electrical stimulation devices (ESDs) used for self-injurious or aggressive…
On April 11, the U.S. the Food and Drug Administration (FDA) approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia who…
Compared to methylprednisolone, topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and is associated with fewer hypertensive side effects in…
A study in Pediatrics reports that the rates of ear infections during an infant’s first year have declined; the investigators suggest that higher rates…
On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC) whose tumors…
On March 4, the Food and Drug Administration (FDA) approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults…
Early Childhood Friendship Project, an eight-week program, reduced bullying behaviors in preschool children, according to a study in School Psychology Review. Read more
A Telephone Cardiopulmonary Resuscitation (TCPR) program increased survival rates and favorable outcomes for patients who experienced an out-of-hospital cardiac arrest, according to…
Compared to methylprednisolone, topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and is associated with fewer hypertensive side…
On March 4, the Food and Drug Administration (FDA) approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children…
Early Childhood Friendship Project, an eight-week program, reduced bullying behaviors in preschool children, according to a study in School Psychology Review. Read…